Medical diagnostics company Guardant Health has sued rival Natera in California federal court for allegedly stealing trade ...

Here is how Guardant Health (GH) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.

Guggenheim restated their buy rating on shares of Guardant Health (NASDAQ:GH – Free Report) in a report released on Monday ...

Guardant Health (NYSE:GH) reported fourth-quarter adjusted EPS loss of 62 cents, compared to a loss of 64 cents a year ago, ...

Scotiabank raised the firm’s price target on Guardant Health (GH) to $52 from $47 and keeps an Outperform rating on the shares. Guardant Health ...

Guardant Health (NASDAQ:GH – Get Free Report) had its target price boosted by research analysts at The Goldman Sachs Group ...

The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.

Guardant Health is overcoming skepticism with new cancer tests. Learn why GH stock is a buy, with strong growth and a shift ...

Canaccord analyst Kyle Mikson raised the firm’s price target on Guardant Health (GH) to $60 from $42 and keeps a Buy rating on the shares. The ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

Explore Guardant Health's Q4 2024 earnings report, highlighting record revenue, Shield's commercial milestones, and a strong 2025 growth outlook.

PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — Guardant Health Inc. (GH) on Thursday reported a loss of $111 million in its fourth quarter. On a per-share basis, the Palo Alto, California-based ...